Quarterly report pursuant to Section 13 or 15(d)

Notes Payable and Convertible Notes Payable (Details)

v3.22.2.2
Notes Payable and Convertible Notes Payable (Details) - USD ($)
1 Months Ended 6 Months Ended 12 Months Ended 36 Months Ended
Jun. 22, 2022
May 25, 2022
Apr. 26, 2022
Jun. 04, 2021
Mar. 02, 2015
Jun. 30, 2013
Jun. 29, 2013
May 07, 2012
Dec. 31, 2011
Feb. 28, 2022
Sep. 27, 2021
Jun. 25, 2021
May 31, 2018
Sep. 30, 2016
Aug. 31, 2016
Dec. 31, 2013
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Dec. 31, 2019
Jun. 03, 2021
May 18, 2022
Mar. 31, 2022
Dec. 14, 2020
Jan. 03, 2020
Sep. 01, 2018
Notes Payable and Convertible Notes Payable (Details) [Line Items]                                                    
Accrued interest                                 $ 61,008   $ 55,008              
Advance from related party                                 1,635,000                  
Aggregate amount                                   $ 410,000                
Outstanding notes                                 $ 297,820                  
Description of board of directors         Platt was required to reimburse the Company to $82,355 and to offset this amount against interest accrued in respect of the outstanding note payable to Dr. Platt. In addition, the Board determined that Dr. Platt would be charged interest related to the $182,697 indemnification payment since funds were received by Dr. Platt in July 2014. The Board of Directors concluded the foregoing constituted complete satisfaction of Dr. Platt’s indemnification by the Company. Accordingly, the Company recorded the reduction in accrued interest through equity during the year ended December 31, 2015. As of March 31, 2022 and December 31, 2021, the balance of the notes payable to Dr. Platt totaled $277,821 and are included in notes payable.                     Platt for legal costs incurred in connection with an arbitration (now concluded) initiated before the American Arbitration Association by Galectin Therapeutics, Inc. (formerly named Pro-Pharmaceuticals, Inc.) for which Dr. Platt previously served as CEO and Chairman. Galectin sought to rescind or reform the Separation Agreement entered into with Dr. Platt upon his resignation from Galectin to remove a $1.0 million milestone payment which Dr. Platt asserted he was entitled to receive and to be repaid all separation benefits paid to Dr. Platt. The Company initially capped the amount for which it would indemnify Dr. Platt at $150,000 in December 2013 and Dr. Platt agreed to reimburse the indemnification amounts paid by the Company should he prevail in the arbitration. The Board decided to indemnify Dr. Platt after considering a number of factors, including the scope of the Company’s existing indemnification obligations to officers and directors and the potential impact of the arbitration on the Company. In May 2014, the Board approved a $50,000 increase in indemnification support, solely for the payment of outside legal expenses. The Company recorded a total of $182,697 in costs associated with Dr. Platt’s indemnification, of which $119,401 was expensed in the year ended December 31, 2013 and of which $63,296 was expensed in the year ended December 31, 2014. In July 2014, the arbitration was concluded in favor of Dr. Platt, confirming the effectiveness of the separation agreement and payment was made to Dr. Platt in July 2014.                    
Note payable marketing, description                                 ●A marketing fee of $850,000, for development of video content and an electronic press kit which will be used ongoing to support product marketing. This fee is paid with a promissory note of $450,000 and a number of shares of stock of the Company valued at $400,000 in accrued expenses, based on the closing price on the day prior to the effective date; ●Quarterly fees for the first two years of up to $100,000 and issuance of 100,000 shares each quarter, based on sales volumes. The Company has the right to make all the stock payments in cash; and  ●a royalty of 5% of the gross licensed marks sales up to $10,000,000, 7.5% royalty on sales from $10,000,000 to $50,000,0000 and 10% on sales over $50,000,000,payable monthly as well as a 1% of all revenue for all Company products as of the date hereof.                  
Matures amount                                       $ 750,000            
Principal balance of the marketing note                                 $ 400,000   450,000              
Accrued interest                                 144,493   126,493              
Accrued expenses                                 400,000   400,000              
Warrant exercisable price per share (in Dollars per share)                     $ 1.1717 $ 1.1717                       $ 0.058 $ 0.058 $ 0.058
Note balance amount       $ 10,639,615.96                         200,000   200,000              
Unamortized discount net                                 250,000   125,000              
Amortization discount amount                                 $ 125,000 0                
Convertible Debentures [Member]                                                    
Notes Payable and Convertible Notes Payable (Details) [Line Items]                                                    
Senior convertible debentures aggregate amount                           $ 1,600,000 $ 1,600,000                      
Aggregate net cash proceeds                           $ 1,327,300 $ 1,327,300                      
Convertible Debentures [Member]                                                    
Notes Payable and Convertible Notes Payable (Details) [Line Items]                                                    
Description of conversion feature                                 The Convertible Debentures have a stated interest rate of 6% per annum payable quarterly beginning June 30, 2017 and were due two years from the date of issuance, the latest due September 15, 2018 and are convertible into shares of the Company’s common stock at the option of the holder at a conversion price of $0.075 with certain anti-dilutive (reset) provisions and are subject to forced conversion if either i) the volume weighted average common stock price for each of any 10 consecutive trading days equals or exceeds $0.50, or (ii) the Company’s elects to lists a class of securities on a national securities exchange.                  
Convertible notes payable balance                                 $ 200,000   200,000              
Convertible Notes Payable [Member]                                                    
Notes Payable and Convertible Notes Payable (Details) [Line Items]                                                    
Convertible note payable, description       On June 4,2021 as a part of merger, the principal amount and accrued interest were converted into 571,621 shares of Common Stock, fully converting the notes and accrued interest as of June 30, 2021.                                            
Debt principle amount                       $ 1,603,778                            
Debt maturity date                       Jun. 25, 2023                            
Senior Notes [Member]                                                    
Notes Payable and Convertible Notes Payable (Details) [Line Items]                                                    
Accrued interest                       $ 603,778                            
Secured notes payable                         $ 1,000,000                          
Senior Secured Convertible Note [Member]                                                    
Notes Payable and Convertible Notes Payable (Details) [Line Items]                                                    
Secured notes payable                       $ 1,000,000                            
Outstanding cash percentage                       115.00%                            
Note holder granted shares (in Shares)                       1,368,762                            
Warrants exercisable term                       2 years                            
Warrant exercisable price per share (in Dollars per share)                       $ 1.1717                            
Modification of debt loss                                     2,385,204              
CJY Holdings Ltd [Member]                                                    
Notes Payable and Convertible Notes Payable (Details) [Line Items]                                                    
Accrued interest                                 $ 36,874   23,485              
Notes payable total amount                                     270,000              
Interest rate                                 10.00%                  
Notes payable                                 $ 270,000   270,000              
Note Payable Marketing [Member]                                                    
Notes Payable and Convertible Notes Payable (Details) [Line Items]                                                    
Notes payable                                       $ 450,000            
Interest rate                                       8.00%            
Principal balance of the marketing note                                 450,000                  
Dr David Platt [Member]                                                    
Notes Payable and Convertible Notes Payable (Details) [Line Items]                                                    
Advance from related party                 $ 257,820                                  
Interest rate             6.50%                                      
Dr David Platt [Member] | Promissory Note [Member]                                                    
Notes Payable and Convertible Notes Payable (Details) [Line Items]                                                    
Advance from related party               $ 20,000                                    
Interest rate           6.50%                                        
Aggregate amount               $ 40,000                                    
Gold Blaze Limited Vistra Corporate Services [Member]                                                    
Notes Payable and Convertible Notes Payable (Details) [Line Items]                                                    
Debt principle amount                   $ 111,111   $ 500,000                            
Debt maturity date                   Feb. 28, 2024   Jun. 25, 2023                            
Outstanding cash percentage                   115.00%   115.00%                            
Note holder granted shares (in Shares)                   94,829   426,730                            
Warrants exercisable term                   5 years   5 years                            
Warrant exercisable price per share (in Dollars per share)                   $ 1.1717   $ 1.1717                            
Beneficial conversion feature discount amount                   $ 100,000   $ 500,000                            
Unamortized discount net                                 18,519   0              
Amortization discount amount                                 18,519 0                
Funds received                   100,000                                
Original issue discount                   11,111                                
HT Investment MA LLC [Member]                                                    
Notes Payable and Convertible Notes Payable (Details) [Line Items]                                                    
Debt principle amount                       $ 5,000,000                            
Debt maturity date                       Jun. 25, 2023                            
Outstanding cash percentage                       115.00%                            
Note holder granted shares (in Shares)                       4,267,304                            
Warrants exercisable term                       5 years                            
Warrant exercisable price per share (in Dollars per share)                       $ 1.1717                            
Beneficial conversion feature discount amount                       $ 4,500,000                            
Unamortized discount net                                 2,500,000   1,250,000              
Amortization discount amount                                 1,250,000 0                
Funds received amount                       4,500,000                            
Original issue discount                       $ 500,000                            
Dr. Harold Parnes [Member]                                                    
Notes Payable and Convertible Notes Payable (Details) [Line Items]                                                    
Debt principle amount                     $ 1,200,000                              
Debt maturity date                     Sep. 27, 2023                              
Outstanding cash percentage                     115.00%                              
Note holder granted shares (in Shares)                     1,024,153                              
Warrants exercisable term                     5 years                              
Warrant exercisable price per share (in Dollars per share)                     $ 1.1717                              
Beneficial conversion feature discount amount                     $ 222,534                              
Unamortized discount net                                 754,654   575,320              
Amortization discount amount                                 179,334 0                
Fair value of warrant discount                     494,802                              
Steve Schrader [Member]                                                    
Notes Payable and Convertible Notes Payable (Details) [Line Items]                                                    
Debt principle amount                     $ 131,000                              
Debt maturity date                     Sep. 27, 2023                              
Outstanding cash percentage                     115.00%                              
Note holder granted shares (in Shares)                     113,510                              
Warrants exercisable term                     5 years                              
Warrant exercisable price per share (in Dollars per share)                     $ 1.1717                              
Beneficial conversion feature discount amount                     $ 24,672                              
Unamortized discount net                                   0                
Amortization discount amount                                 69,033 0                
Fair value of warrant discount                     $ 54,598                              
Common stock debt discount (in Shares)                                           111,803        
Unamortized discount                                     61,967              
Zygote Ventures [Member]                                                    
Notes Payable and Convertible Notes Payable (Details) [Line Items]                                                    
Debt principle amount                   $ 111,111                                
Debt maturity date                   Feb. 28, 2024                                
Outstanding cash percentage                   115.00%                                
Note holder granted shares (in Shares)                   94,829                                
Warrants exercisable term                   5 years                                
Warrant exercisable price per share (in Dollars per share)                   $ 1.1717                                
Beneficial conversion feature discount amount                   $ 100,000                                
Unamortized discount net                                 18,519   0              
Amortization discount amount                                 18,519 0                
Funds received amount                   100,000                                
Original issue discount                   11,111                                
Garrett Gruener [Member]                                                    
Notes Payable and Convertible Notes Payable (Details) [Line Items]                                                    
Debt principle amount $ 366,667 $ 394,444 $ 611,111             $ 444,444                                
Debt maturity date Jun. 22, 2024 May 25, 2024 Apr. 26, 2024             Feb. 28, 2024                                
Outstanding cash percentage 115.00% 115.00% 115.00%             115.00%                                
Note holder granted shares (in Shares) 469,404 504,964 782,340             379,316                                
Warrants exercisable term 5 years 5 years 5 years             5 years                                
Warrant exercisable price per share (in Dollars per share) $ 1.1717 $ 1.1717 $ 1.1717             $ 1.1717                                
Beneficial conversion feature discount amount $ 123,410 $ 77,945 $ 550,000             $ 400,000                                
Unamortized discount net                                 208,369   0              
Amortization discount amount                                 1,779 0                
Funds received amount 330,000 163,631 550,000             400,000                                
Original issue discount $ 36,667 $ 355,000 $ 61,111             $ 44,444                                
Common stock debt discount (in Shares)   39,444                                                
Garrett Gruener [Member] | Senior Notes [Member]                                                    
Notes Payable and Convertible Notes Payable (Details) [Line Items]                                                    
Unamortized discount net                                 74,074   0              
Amortization discount amount                                 74,074 0                
Senior Secured Convertible Note [Member]                                                    
Notes Payable and Convertible Notes Payable (Details) [Line Items]                                                    
Note balance amount                                     1,603,778       $ 1,603,778      
Notes Payable, Other Payables [Member]                                                    
Notes Payable and Convertible Notes Payable (Details) [Line Items]                                                    
Accrued interest                                     127,575       $ 135,942      
Notes Payable, Other Payables [Member] | Garrett Gruener [Member]                                                    
Notes Payable and Convertible Notes Payable (Details) [Line Items]                                                    
Unamortized discount net                                 127,474   $ 0              
Amortization discount amount                                 14,051 0                
Convertible Notes Payable [Member]                                                    
Notes Payable and Convertible Notes Payable (Details) [Line Items]                                                    
Stock Issued                                         $ 8,700,000          
Related parties                                         7,700,000          
Interest rate                                     15.00%              
Warrant interest rate                                     30.00%              
Special preferred stock                                     $ 0.32276              
Notes convert, per share (in Dollars per share)                                     $ 0.10759              
Accrued interest                                         $ 1,960,116          
Convertible Notes Payable [Member] | Garrett Gruener [Member]                                                    
Notes Payable and Convertible Notes Payable (Details) [Line Items]                                                    
Unamortized discount net                                 54,321   $ 0              
Amortization discount amount                                 $ 54,321 $ 0